ClinicalTrials.gov
public full text
Public Domain
Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype
This study is designed to assess the physiological consequences of elevating Nicotinamide Adenine Dinucleotide (NAD+) availability using Nicotinamide Riboside (NR) supplementation in skeletal muscle tissue, and examine its effect upon muscle metabolic phenotype.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dehydroascorbic acid, the oxidized form of vitamin C, improves renal histology and function in old mice#1092449
- Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults#1125046
- Amino Acids and Exercise in FSHD#912649
- The Effect of Exercise Training on Skeletal Muscle Metabolism in Peripheral Artery Disease (PAD)#867987
- A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor#67840
Record · ID 841349
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive